Dailypharm Live Search Close

¡®Prevent MI recurrence through efficient LDL-C control'

By Whang, byung-woo | translator Alice Kang

24.11.05 05:37:55

°¡³ª´Ù¶ó 0
Dong-Oh Kang, Professor, Department of Cardiology, Korea University Guro Hospital

Proposes LDL-C level below 55 mg/dL as the optimal treatment condition

Diverse treatment strategies introduced with the emergence of new drugs...emphasizes personalized treatment

With the rise of metabolic diseases such as hypertension, diabetes, and hyperlipidemia increase in Korea, the prevalence of myocardial infarction and atherosclerotic cardiovascular diseases are also on the rise.

The mortality rate of myocardial infarction is in the 20-30% range when it occurs for the first time, but the mortality rate increases sharply to 68-85% when it recurs, which is why efforts to prevent recurrence are being stressed now.

In particular, one of the hot topics in treatment is how to manage LDL cholesterol, which is known to be an important factor in preventing the recurrence of atherosclerotic cardiovascular disease (ASCVD).

In recent years, treatment opt

Whang, byung-woo(tuai@dailypharm.com)
If you want to see the full article, please JOIN US (click)